Literature DB >> 31495376

Do We Know Enough to Prescribe Opioid-Agonist Therapies to Adolescents With Problematic Opioid Use? A Commentary on Camenga et al. (2019).

Noel Vest1, Keith N Humphreys1,2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31495376      PMCID： PMC6739645     

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN： 1937-1888            Impact factor:   2.582


× No keyword cloud information.
  6 in total

1.  Drug policy and the public good: evidence for effective interventions.

Authors:  John Strang; Thomas Babor; Jonathan Caulkins; Benedikt Fischer; David Foxcroft; Keith Humphreys
Journal:  Lancet       Date:  2012-01-07       Impact factor: 79.321

Review 2.  Adolescent cortical development: a critical period of vulnerability for addiction.

Authors:  Fulton Crews; Jun He; Clyde Hodge
Journal:  Pharmacol Biochem Behav       Date:  2007-01-12       Impact factor: 3.533

3.  Alcohol problems need more attention in patients receiving long-term opioid substitution therapy.

Authors:  Wayne D Hall; John Strang
Journal:  Lancet Psychiatry       Date:  2017-03-01       Impact factor: 27.083

4.  Non-buprenorphine opioid utilization among patients using buprenorphine.

Authors:  Matthew Daubresse; Brendan Saloner; Harold A Pollack; G Caleb Alexander
Journal:  Addiction       Date:  2017-02-23       Impact factor: 6.526

Review 5.  Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine.

Authors:  M J Kreek
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 6.  Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.

Authors:  Deepa R Camenga; Hector A Colon-Rivera; Srinivas B Muvvala
Journal:  J Stud Alcohol Drugs       Date:  2019-07       Impact factor: 2.582
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.